RhoA-dependent PAI-1 gene expression induced in endothelial cells by monocyte adhesion mediates geranylgeranyl transferase I and Ca2+ signaling

Atherosclerosis

Volumn 193, Issue 1, 2007, Pages 44-54

  Sakamoto, Takayuki ^a   Ishibashi, Toshiyuki ^a   Sugimoto, Koichi ^a   Sakamoto, Nobuo ^a   Ohkawara, Hiroshi ^a   Niinuma, Miki ^a   Nagata, Kenji ^a   Kamioka, Masashi ^a   Sugimoto, Naotoshi ^b   Watanabe, Atai ^c   Kurabayashi, Masahiko ^c   Takuwa, Yoh ^b   Maruyama, Yukio ^a  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^b KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

^c GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Ca2+; Geranylgeranyl transferase I; Monocyte endothelial cell interaction; Plasminogen activator inhibitor 1; RhoA

Indexed keywords

ACTIN; CALCIUM ION; ENZYME INHIBITOR; EXOENZYME C3; GERANYLGERANYL TRANSFERASE 1; GERANYLTRANSFERASE; GGTI 286; PLASMINOGEN ACTIVATOR INHIBITOR 1; PRAVASTATIN; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; ATHEROGENESIS; CALCIUM SIGNALING; CELL ADHESION; CORONARY ARTERY; CORONARY ARTERY DISEASE; ENDOTHELIUM CELL; ENZYME ACTIVITY; GENE EXPRESSION; HUMAN; HUMAN CELL; MONOCYTE; PRIORITY JOURNAL; THROMBOGENESIS; UPREGULATION;

ACTINS; ALKYL AND ARYL TRANSFERASES; CALCIUM SIGNALING; CELL ADHESION; CELLS, CULTURED; COCULTURE TECHNIQUES; CYTOSKELETON; ENDOTHELIAL CELLS; GENE EXPRESSION; HUMANS; MONOCYTES; PLASMINOGEN ACTIVATOR INHIBITOR 1; PRAVASTATIN; RHOA GTP-BINDING PROTEIN; RNA STABILITY; RNA, MESSENGER;

EID: 34248668994     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2006.08.036     Document Type: Article

References (25)

1. Kohler H.P., and Grant P.J. Plasminogen-activator inhibitor type 1 and coronary artery disease. N Engl J Med 342 (2000) 1792-1801
2. Shindo J., Ishibashi T., Kijima M., et al. Increased plasminogen activator inhibitor-1 and apolipoprotein (a) in coronary atherectomy specimens in acute coronary syndromes. Coron Artery Dis 12 (2001) 573-579
3. Corti R., Fuster V., and Badimon J.J. Pathogenic concepts of acute coronary syndromes. J Am Coll Cardiol 41 4 Suppl S (2003) 7S-14S
4. Tipping P.G., Davenport P., Gallicchio M., et al. Atheromatous plaque macrophages produce plasminogen activator inhibitor type-1 and stimulate its production by endothelial cells and vascular smooth muscle cells. Am J Pathol 143 (1993) 875-885
5. Essing M., Nguyen G., Prie D., et al. 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors increase fibrinolytic activity in rat aortic endothelial cells. Role of geranylgeranylation and Rho proteins. Circ Res 83 (1998) 683-690
6. Takeda K., Ichiki T., Tokunou T., et al. Critical role of Rho-kinase and MEK/ERK pathways for angiotensin II-induced plasminogen activator inhibitor type-1 gene expression. Arterioscler Thromb Vasc Biol 21 (2001) 868-873
7. Ishibashi T., Nagata K., Ohkawara H., et al. Inhibition of Rho/Rho-kinase signaling downregulates plasminogen activator inhibitor-1 synthesis in cultured human monocytes. Biochim Biophys Acta 1590 (2002) 123-130
8. Ishibashi T., Sakamoto T., Ohkawara H., et al. Integral role of RhoA activation in monocyte adhesion-triggered tissue factor expression in endothelial cells. Arterioscler Thromb Vasc Biol 23 (2003) 681-687
9. 2+ influx through MCP-1 in endothelial cells by monocyte adhesion. Arterioscler Thromb Vasc Biol 25 (2005) 2005-2011
10. Ziegelstein R.C., Corda S., Pili R., et al. Initial contact and subsequent adhesion of human neutrophils or monocytes to human aortic endothelial cells releases an endothelial intracellular calcium store. Circulation 90 (1994) 1899-1907
11. Peiretti F., Fossat C., Anfosso F., et al. Increase in cytosolic calcium upregulates the synthesis of type 1 plasminogen activator inhibitor in the human histiocytic cell line U937. Blood 87 (1996) 162-173
12. Yokoyama K., Ishibashi T., Ohkawara H., et al. HMG-CoA reductase inhibitors suppress intracellular calcium mobilization and membrane current induced by lysophosphatidylcholine in endothelial cells. Circulation 105 (2002) 962-967
13. Li L., Matsuoka I., Suzuki Y., et al. Inhibitory effect of fluvastatin on lysophosphatidylcholine-induced nonselective cation current in Guinea pig ventricular myocytes. Mol Pharmacol 62 (2002) 602-607
14. Nagata K., Ishibashi T., Sakamoto T., et al. Effects of blockade of the renin-angiotensin system on tissue factor and plasminogen activator inhibitor-1 synthesis in human cultured monocytes. J Hypertens 19 (2001) 775-783
15. Maeda S., Matsuoka I., Iwamoto T., et al. Down-regulation of Na+/Ca2+ exchanger by fluvastatin in rat cardiomyoblast H9c2 cells: involvement of RhoB in Na+/Ca2+ exchanger mRNA stability. Mol Pharmacol 68 (2005) 414-420
16. Uchiyama T., Kurabayashi M., Ohyama Y., et al. Hypoxia induces transcription of the plasminogen activator inhibitor-1 gene through genistein-sensitive tyrosine kinase pathways in vascular endothelial cells. Arterioscler Thromb Vasc Biol 20 (2000) 1155-1161
17. Kaneko T., Fujii S., Matsumoto A., et al. Induction of plasminogen activator inhibitor-1 in endothelial cells by basic fibroblast growth factor and its modulation by fibric acid. Arterioscler Thromb Vasc Biol 22 (2002) 855-860
18. Ryu Y., Takuwa N., Sugimoto N., et al. Sphingosine-1-phosphate, a platelet-derived lysophospholipid mediator, negatively regulates cellular Rac activity and cell migration in vascular smooth muscle cells. Circ Res 90 (2002) 325-332
19. Ohkawara H., Ishibashi T., Sakamoto T., et al. Thrombin-induced rapid geranylgeranylation of RhoA as an essential process for RhoA activation in endothelial cells. J Biol Chem 280 (2005) 10182-10188
20. Chappell J., Golovchenko I., Wall K., et al. Potentiation of Rho-A-mediated lysophosphatidic acid activity by hyperinsulinemia. J Biol Chem 275 (2000) 31792-31797
21. Wojciak-Stothard B., Williams L., Ridley A.J., et al. Monocyte adhesion and spreading on human endothelial calls is dependent on Rho-regulated receptor clustering. J Cell Biol 145 (1999) 1293-1307
22. Yoshida M., Sawada T., Ishii H., et al. HMG-CoA reductase inhibitor modulates monocyte-endothelial cell interaction under physiological flow conditions in vitro: Involvement of Rho GTPase-dependent mechanism. Arterioscler Thromb Vasc Biol 21 (2001) 1165-1171
23. Eren M., Painter C.A., Atkinson J.B., et al. Age-dependent spontaneous coronary arterial thrombosis in transgenic mice that express a stable form of human plasminogen activator inhibitor-1. Circulation 106 (2002) 491-496
24. Sabatier F., Roux V., Anfosso F., et al. Interaction of endothelial microparticles with monocyte cells in vitro induces tissue factor-dependent procoagulant activity. Blood 99 (2002) 3962-3970
25. Wassmann S., Faul A., Hennen B., et al. Rapid effect of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition on coronary endothelial function. Circ Res 93 (2003) e98-e103